Hislop School of Biotechnology, Hislop College, Nagpur, Maharashtra, India.
J Pept Sci. 2011 Jun;17(6):438-44. doi: 10.1002/psc.1341. Epub 2011 Feb 4.
Nisin is a peptide bacteriocin, grouped under the category of lantibiotics. It is naturally produced by Lactococcus lactis to eliminate other competing gram-positive bacteria from its vicinity. Moreover under certain conditions it is reported to be effective against a broad range of gram-negative bacteria as well. Thus, it has been widely used as a safe food preservative especially in the dairy industry. Because of its wide-scale consumption, its effect on eukaryotic cells should be of great concern. Here we examine the immunomodulatory efficacy of nisin in vitro. MTT-based cytotoxicity assay demonstrated nisin's cytotoxicity on human T-cell lymphoma Jurkat cells, Molt-4 cells and freshly cultured human lymphocytes at over 200 µM concentration (IC(50) 225 µM). The cell death mechanism induced by nisin in all these lymphocyte types was independent of oligonucleosomal DNA fragmentation, as analyzed by agarose gel electrophoresis and comet assay. Additionally, scanning electron microscope and fluorescence microscopy demonstrated the ability of nisin to activate human PMNs in vitro. Nisin-activated neutrophils extruded intact nuclear chromatin to form NETs, well known for neutralization of virulence factors and extermination of bacterial pathogens. Nisin's presence also elevated neutrophil intracellular superoxide levels, normally produced by activated NADPH oxidase and prerequisite to NET formation. These nisin-induced responses in cellular representatives of two separate branches of human immune system-adaptive and innate-although leading to cell death, did not include DNA fragmentation. From these findings, we propose that nisin might trigger similar AICD mechanisms in lymphocytes and neutrophils, different from conventional apoptosis which involves DNA fragmentation.
乳链菌肽是一种肽类细菌素,属于羊毛硫抗生素。它是由乳球菌自然产生的,用于消除其周围其他竞争的革兰氏阳性菌。此外,在某些条件下,它被报道对广泛的革兰氏阴性菌也有效。因此,它已被广泛用作安全的食品防腐剂,特别是在乳制品行业。由于其广泛的消费,它对真核细胞的影响应该引起极大的关注。在这里,我们检查了乳链菌肽在体外的免疫调节功效。MTT 基础细胞毒性测定法表明,乳链菌肽在 200µM 浓度以上对人 T 细胞淋巴瘤 Jurkat 细胞、Molt-4 细胞和新鲜培养的人淋巴细胞具有细胞毒性(IC50 为 225µM)。用琼脂糖凝胶电泳和彗星试验分析,发现乳链菌肽在所有这些淋巴细胞类型中诱导的细胞死亡机制与寡核小体 DNA 片段化无关。此外,扫描电子显微镜和荧光显微镜显示了乳链菌肽在体外激活人 PMN 的能力。乳链菌肽激活的中性粒细胞将完整的核染色质挤出,形成众所周知的用于中和毒力因子和消灭细菌病原体的 NETs。乳链菌肽的存在还增加了中性粒细胞内的超氧阴离子水平,这通常是由激活的 NADPH 氧化酶产生的,是 NET 形成的必要条件。这些在人类免疫系统适应性和固有性的两个不同分支的细胞代表中诱导的乳链菌肽反应,虽然导致细胞死亡,但不包括 DNA 片段化。从这些发现中,我们提出乳链菌肽可能在淋巴细胞和中性粒细胞中触发类似的 AICD 机制,与涉及 DNA 片段化的传统细胞凋亡不同。